![Wake Forest University School of Divinity | $5 Million grant brings Gilead COMPASS Faith Coordinating Center to Wake Forest University School of Divinity to combat HIV/AIDS in the South Wake Forest University School of Divinity | $5 Million grant brings Gilead COMPASS Faith Coordinating Center to Wake Forest University School of Divinity to combat HIV/AIDS in the South](https://prod.wp.cdn.aws.wfu.edu/sites/223/2020/05/20171115campus6348-scaled.jpg)
Wake Forest University School of Divinity | $5 Million grant brings Gilead COMPASS Faith Coordinating Center to Wake Forest University School of Divinity to combat HIV/AIDS in the South
![GILD Stock: Gilead Plots A Massive Move Into Oncology With A Third Of Sales By 2030 | Investor's Business Daily GILD Stock: Gilead Plots A Massive Move Into Oncology With A Third Of Sales By 2030 | Investor's Business Daily](https://www.investors.com/wp-content/uploads/2020/06/Stock-gilead-07-adobe.jpg)
GILD Stock: Gilead Plots A Massive Move Into Oncology With A Third Of Sales By 2030 | Investor's Business Daily
![Gilead's Yescarta set to become England's first routinely available personalized immunotherapy for lymphoma Gilead's Yescarta set to become England's first routinely available personalized immunotherapy for lymphoma](https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/biopharma-reporter.com/headlines/markets-regulations/gilead-s-yescarta-set-to-become-england-s-first-routinely-available-personalized-immunotherapy-for-lymphoma/16117967-8-eng-GB/Gilead-s-Yescarta-set-to-become-England-s-first-routinely-available-personalized-immunotherapy-for-lymphoma.jpg)